| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | androsterone dehydrogenase (B-specific) activity | 9.31e-07 | 4 | 124 | 3 | GO:0047042 | |
| GeneOntologyMolecularFunction | ketoreductase activity | 9.31e-07 | 4 | 124 | 3 | GO:0045703 | |
| GeneOntologyMolecularFunction | chlordecone reductase activity | 9.31e-07 | 4 | 124 | 3 | GO:0047743 | |
| GeneOntologyMolecularFunction | trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity | 2.32e-06 | 5 | 124 | 3 | GO:0047115 | |
| GeneOntologyMolecularFunction | 15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity | 2.32e-06 | 5 | 124 | 3 | GO:0047020 | |
| GeneOntologyMolecularFunction | 17-beta-ketosteroid reductase (NADPH) activity | 2.32e-06 | 5 | 124 | 3 | GO:0072555 | |
| GeneOntologyMolecularFunction | 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity | 2.32e-06 | 5 | 124 | 3 | GO:0047006 | |
| GeneOntologyMolecularFunction | lithocholic acid binding | 2.32e-06 | 5 | 124 | 3 | GO:1902121 | |
| GeneOntologyMolecularFunction | ketosteroid monooxygenase activity | 2.32e-06 | 5 | 124 | 3 | GO:0047086 | |
| GeneOntologyMolecularFunction | Delta4-3-oxosteroid 5beta-reductase activity | 2.32e-06 | 5 | 124 | 3 | GO:0047787 | |
| GeneOntologyMolecularFunction | microfilament motor activity | 3.63e-06 | 38 | 124 | 5 | GO:0000146 | |
| GeneOntologyMolecularFunction | geranylgeranyl reductase activity | 4.61e-06 | 6 | 124 | 3 | GO:0045550 | |
| GeneOntologyMolecularFunction | 17-beta-hydroxysteroid dehydrogenase (NADP+) activity | 8.03e-06 | 7 | 124 | 3 | GO:0072582 | |
| GeneOntologyMolecularFunction | 5alpha-androstane-3beta,17beta-diol dehydrogenase activity | 1.28e-05 | 8 | 124 | 3 | GO:0047024 | |
| GeneOntologyMolecularFunction | androsterone dehydrogenase activity | 1.28e-05 | 8 | 124 | 3 | GO:0047023 | |
| GeneOntologyMolecularFunction | enone reductase activity | 1.28e-05 | 8 | 124 | 3 | GO:0035671 | |
| GeneOntologyMolecularFunction | androstan-3-alpha,17-beta-diol dehydrogenase activity | 1.91e-05 | 9 | 124 | 3 | GO:0047044 | |
| GeneOntologyMolecularFunction | NADP+ binding | 1.91e-05 | 9 | 124 | 3 | GO:0070401 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the aldehyde or oxo group of donors | 2.52e-05 | 56 | 124 | 5 | GO:0016903 | |
| GeneOntologyMolecularFunction | testosterone 17-beta-dehydrogenase (NADP+) activity | 2.72e-05 | 10 | 124 | 3 | GO:0047045 | |
| GeneOntologyMolecularFunction | bile acid binding | 2.72e-05 | 10 | 124 | 3 | GO:0032052 | |
| GeneOntologyMolecularFunction | aldose reductase (NADPH) activity | 8.09e-05 | 14 | 124 | 3 | GO:0004032 | |
| GeneOntologyMolecularFunction | retinal dehydrogenase activity | 8.09e-05 | 14 | 124 | 3 | GO:0001758 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 9.49e-05 | 118 | 124 | 6 | GO:0003774 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | MYH6 MYH7 MYH10 ERCC6L KIF21A DDX42 PSMC1 CCT2 UPF1 IGHMBP2 MYH15 ATP6V0D2 MYO15A | 1.17e-04 | 614 | 124 | 13 | GO:0140657 |
| GeneOntologyMolecularFunction | tRNA binding | 2.10e-04 | 87 | 124 | 5 | GO:0000049 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor | 2.23e-04 | 48 | 124 | 4 | GO:0016620 | |
| GeneOntologyMolecularFunction | double-stranded DNA helicase activity | 2.28e-04 | 4 | 124 | 2 | GO:0036121 | |
| GeneOntologyMolecularFunction | indanol dehydrogenase activity | 2.28e-04 | 4 | 124 | 2 | GO:0047718 | |
| GeneOntologyMolecularFunction | estradiol 17-beta-dehydrogenase [NAD(P)+] activity | 2.47e-04 | 20 | 124 | 3 | GO:0004303 | |
| GeneOntologyMolecularFunction | SUMO ligase activity | 2.47e-04 | 20 | 124 | 3 | GO:0061665 | |
| GeneOntologyMolecularFunction | all-trans-retinol dehydrogenase (NAD+) activity | 4.30e-04 | 24 | 124 | 3 | GO:0004745 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase (NAD+) activity | 5.47e-04 | 26 | 124 | 3 | GO:0004022 | |
| GeneOntologyMolecularFunction | NADPH binding | 5.47e-04 | 26 | 124 | 3 | GO:0070402 | |
| GeneOntologyMolecularFunction | calmodulin binding | 5.91e-04 | 230 | 124 | 7 | GO:0005516 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase (NADP+) activity | 6.13e-04 | 27 | 124 | 3 | GO:0008106 | |
| GeneOntologyMolecularFunction | transcription factor binding | DCAF13 TRIB2 WFS1 FOS PSMC1 NR4A3 BCOR CRY1 TBX18 FAM220BP ZBTB7A IGHMBP2 PRKDC | 8.22e-04 | 753 | 124 | 13 | GO:0008134 |
| GeneOntologyMolecularFunction | alcohol dehydrogenase [NAD(P)+] activity | 8.40e-04 | 30 | 124 | 3 | GO:0018455 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | DCAF13 TRIB2 WFS1 FOS NR4A3 BCOR CRY1 TBX18 FAM220BP ZBTB7A PRKDC | 1.02e-03 | 582 | 124 | 11 | GO:0140297 |
| GeneOntologyMolecularFunction | aldo-keto reductase (NADPH) activity | 1.02e-03 | 32 | 124 | 3 | GO:0004033 | |
| GeneOntologyMolecularFunction | steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 1.11e-03 | 33 | 124 | 3 | GO:0033764 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | 1.19e-03 | 417 | 124 | 9 | GO:0061629 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor | 1.22e-03 | 34 | 124 | 3 | GO:0016628 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor | 1.34e-03 | 9 | 124 | 2 | GO:0016624 | |
| GeneOntologyMolecularFunction | SUMO transferase activity | 1.44e-03 | 36 | 124 | 3 | GO:0019789 | |
| GeneOntologyMolecularFunction | steroid dehydrogenase activity | 1.81e-03 | 39 | 124 | 3 | GO:0016229 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen | 1.95e-03 | 40 | 124 | 3 | GO:0016709 | |
| GeneOntologyMolecularFunction | testosterone dehydrogenase [NAD(P)+] activity | 2.03e-03 | 11 | 124 | 2 | GO:0030283 | |
| GeneOntologyMolecularFunction | actin filament binding | 2.96e-03 | 227 | 124 | 6 | GO:0051015 | |
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | 3.23e-03 | 231 | 124 | 6 | GO:0005085 | |
| GeneOntologyMolecularFunction | diacylglycerol binding | 4.34e-03 | 16 | 124 | 2 | GO:0019992 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on RNA | 4.54e-03 | 417 | 124 | 8 | GO:0140098 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor | 6.18e-03 | 60 | 124 | 3 | GO:0016655 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 6.31e-03 | 441 | 124 | 8 | GO:0016887 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-CH group of donors | 6.77e-03 | 62 | 124 | 3 | GO:0016627 | |
| GeneOntologyMolecularFunction | NADP binding | 6.77e-03 | 62 | 124 | 3 | GO:0050661 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | TRMT10B ERCC6L DDX42 UPF1 DALRD3 NARS2 CRY1 IGHMBP2 EMG1 TRMT13 | 6.97e-03 | 645 | 124 | 10 | GO:0140640 |
| GeneOntologyBiologicalProcess | response to jasmonic acid | 8.45e-07 | 4 | 124 | 3 | GO:0009753 | |
| GeneOntologyBiologicalProcess | progesterone catabolic process | 8.45e-07 | 4 | 124 | 3 | GO:0006709 | |
| GeneOntologyBiologicalProcess | cellular response to jasmonic acid stimulus | 8.45e-07 | 4 | 124 | 3 | GO:0071395 | |
| GeneOntologyBiologicalProcess | C21-steroid hormone catabolic process | 8.45e-07 | 4 | 124 | 3 | GO:0008208 | |
| GeneOntologyBiologicalProcess | farnesol metabolic process | 2.10e-06 | 5 | 124 | 3 | GO:0016487 | |
| GeneOntologyBiologicalProcess | farnesol catabolic process | 2.10e-06 | 5 | 124 | 3 | GO:0016488 | |
| GeneOntologyBiologicalProcess | negative regulation of isoprenoid metabolic process | 2.10e-06 | 5 | 124 | 3 | GO:0045827 | |
| GeneOntologyBiologicalProcess | sesquiterpenoid catabolic process | 2.10e-06 | 5 | 124 | 3 | GO:0016107 | |
| GeneOntologyBiologicalProcess | olefinic compound catabolic process | 2.10e-06 | 5 | 124 | 3 | GO:0120256 | |
| GeneOntologyBiologicalProcess | negative regulation of retinoic acid biosynthetic process | 2.10e-06 | 5 | 124 | 3 | GO:1900053 | |
| GeneOntologyBiologicalProcess | sesquiterpenoid metabolic process | 4.19e-06 | 6 | 124 | 3 | GO:0006714 | |
| GeneOntologyBiologicalProcess | polyprenol catabolic process | 4.19e-06 | 6 | 124 | 3 | GO:0016095 | |
| GeneOntologyBiologicalProcess | response to prostaglandin D | 7.29e-06 | 7 | 124 | 3 | GO:0071798 | |
| GeneOntologyBiologicalProcess | cellular response to prostaglandin D stimulus | 7.29e-06 | 7 | 124 | 3 | GO:0071799 | |
| GeneOntologyBiologicalProcess | regulation of retinoic acid biosynthetic process | 7.29e-06 | 7 | 124 | 3 | GO:1900052 | |
| GeneOntologyBiologicalProcess | daunorubicin metabolic process | 1.74e-05 | 9 | 124 | 3 | GO:0044597 | |
| GeneOntologyBiologicalProcess | doxorubicin metabolic process | 2.47e-05 | 10 | 124 | 3 | GO:0044598 | |
| GeneOntologyBiologicalProcess | regulation of isoprenoid metabolic process | 2.47e-05 | 10 | 124 | 3 | GO:0019747 | |
| GeneOntologyBiologicalProcess | negative regulation of vitamin metabolic process | 2.47e-05 | 10 | 124 | 3 | GO:0046137 | |
| GeneOntologyBiologicalProcess | polyketide metabolic process | 2.47e-05 | 10 | 124 | 3 | GO:0030638 | |
| GeneOntologyBiologicalProcess | aminoglycoside antibiotic metabolic process | 2.47e-05 | 10 | 124 | 3 | GO:0030647 | |
| GeneOntologyBiologicalProcess | regulation of testosterone biosynthetic process | 3.38e-05 | 11 | 124 | 3 | GO:2000224 | |
| GeneOntologyBiologicalProcess | terpenoid catabolic process | 3.38e-05 | 11 | 124 | 3 | GO:0016115 | |
| GeneOntologyBiologicalProcess | retinoic acid biosynthetic process | 7.35e-05 | 14 | 124 | 3 | GO:0002138 | |
| GeneOntologyBiologicalProcess | isoprenoid catabolic process | 7.35e-05 | 14 | 124 | 3 | GO:0008300 | |
| GeneOntologyBiologicalProcess | diterpenoid biosynthetic process | 9.15e-05 | 15 | 124 | 3 | GO:0016102 | |
| GeneOntologyBiologicalProcess | testosterone biosynthetic process | 1.12e-04 | 16 | 124 | 3 | GO:0061370 | |
| GeneOntologyBiologicalProcess | negative regulation of hormone metabolic process | 1.12e-04 | 16 | 124 | 3 | GO:0032351 | |
| GeneOntologyBiologicalProcess | adult heart development | 1.62e-04 | 18 | 124 | 3 | GO:0007512 | |
| GeneOntologyBiologicalProcess | regulation of vitamin metabolic process | 1.62e-04 | 18 | 124 | 3 | GO:0030656 | |
| GeneOntologyBiologicalProcess | myofibril assembly | 1.71e-04 | 86 | 124 | 5 | GO:0030239 | |
| GeneOntologyBiologicalProcess | cellular response to transforming growth factor beta stimulus | 1.99e-04 | 336 | 124 | 9 | GO:0071560 | |
| GeneOntologyBiologicalProcess | striated muscle cell development | 2.01e-04 | 89 | 124 | 5 | GO:0055002 | |
| GeneOntologyBiologicalProcess | intracellular receptor signaling pathway | CGAS CASP4 NR4A3 ZMIZ1 AKR1C1 AKR1C2 CRY1 ZBTB7A AKR1C3 PRKDC | 2.11e-04 | 416 | 124 | 10 | GO:0030522 |
| GeneOntologyBiologicalProcess | response to transforming growth factor beta | 2.32e-04 | 343 | 124 | 9 | GO:0071559 | |
| GeneOntologyBiologicalProcess | hormone catabolic process | 2.61e-04 | 21 | 124 | 3 | GO:0042447 | |
| GeneOntologyBiologicalProcess | terpenoid biosynthetic process | 2.61e-04 | 21 | 124 | 3 | GO:0016114 | |
| GeneOntologyBiologicalProcess | regulation of retinoic acid receptor signaling pathway | 2.61e-04 | 21 | 124 | 3 | GO:0048385 | |
| GeneOntologyBiologicalProcess | retinal metabolic process | 2.61e-04 | 21 | 124 | 3 | GO:0042574 | |
| GeneOntologyBiologicalProcess | ketone catabolic process | 2.61e-04 | 21 | 124 | 3 | GO:0042182 | |
| GeneOntologyBiologicalProcess | parturition | 3.00e-04 | 22 | 124 | 3 | GO:0007567 | |
| GeneOntologyBiologicalProcess | glycoside metabolic process | 3.00e-04 | 22 | 124 | 3 | GO:0016137 | |
| GeneOntologyBiologicalProcess | progesterone metabolic process | 3.00e-04 | 22 | 124 | 3 | GO:0042448 | |
| GeneOntologyBiologicalProcess | tertiary alcohol metabolic process | 3.00e-04 | 22 | 124 | 3 | GO:1902644 | |
| GeneOntologyBiologicalProcess | ear morphogenesis | 3.40e-04 | 154 | 124 | 6 | GO:0042471 | |
| GeneOntologyBiologicalProcess | cellular response to prostaglandin stimulus | 3.44e-04 | 23 | 124 | 3 | GO:0071379 | |
| GeneOntologyBiologicalProcess | primary alcohol catabolic process | 3.44e-04 | 23 | 124 | 3 | GO:0034310 | |
| GeneOntologyBiologicalProcess | atrial cardiac muscle tissue development | 4.43e-04 | 25 | 124 | 3 | GO:0003228 | |
| GeneOntologyBiologicalProcess | positive regulation of epithelial cell apoptotic process | 4.68e-04 | 60 | 124 | 4 | GO:1904037 | |
| GeneOntologyBiologicalProcess | regulation of ketone biosynthetic process | 4.98e-04 | 26 | 124 | 3 | GO:0010566 | |
| GeneOntologyBiologicalProcess | muscle tissue development | MYH6 MYH7 MYH10 DLL4 FOS ITGA8 SPG11 KLHL41 TBX18 CACNA1G MYOM2 | 5.53e-04 | 558 | 124 | 11 | GO:0060537 |
| GeneOntologyBiologicalProcess | cellular response to growth factor stimulus | DLL4 FOS VEPH1 ITGA8 ZMIZ1 AKR1C1 AKR1C2 ZBTB7A SULF1 DSTYK ZMIZ2 AKR1C3 VCAM1 GAB1 | 5.96e-04 | 850 | 124 | 14 | GO:0071363 |
| GeneOntologyBiologicalProcess | cellular response to steroid hormone stimulus | 6.13e-04 | 239 | 124 | 7 | GO:0071383 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA splicing, via spliceosome | 6.22e-04 | 28 | 124 | 3 | GO:0048025 | |
| GeneOntologyBiologicalProcess | polyprenol metabolic process | 6.91e-04 | 29 | 124 | 3 | GO:0016093 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA processing | 6.91e-04 | 29 | 124 | 3 | GO:0050686 | |
| GeneOntologyBiologicalProcess | hormone-mediated signaling pathway | 6.93e-04 | 244 | 124 | 7 | GO:0009755 | |
| GeneOntologyBiologicalProcess | response to growth factor | DLL4 FOS VEPH1 ITGA8 ZMIZ1 AKR1C1 AKR1C2 ZBTB7A SULF1 DSTYK ZMIZ2 AKR1C3 VCAM1 GAB1 | 8.63e-04 | 883 | 124 | 14 | GO:0070848 |
| GeneOntologyBiologicalProcess | positive regulation of endothelial cell apoptotic process | 9.26e-04 | 32 | 124 | 3 | GO:2000353 | |
| GeneOntologyBiologicalProcess | muscle cell development | 9.82e-04 | 259 | 124 | 7 | GO:0055001 | |
| GeneOntologyBiologicalProcess | negative regulation of RNA splicing | 1.01e-03 | 33 | 124 | 3 | GO:0033119 | |
| GeneOntologyBiologicalProcess | Ras protein signal transduction | 1.06e-03 | 128 | 124 | 5 | GO:0007265 | |
| GeneOntologyBiologicalProcess | regulation of mRNA splicing, via spliceosome | 1.10e-03 | 129 | 124 | 5 | GO:0048024 | |
| GeneOntologyBiologicalProcess | inner ear morphogenesis | 1.10e-03 | 129 | 124 | 5 | GO:0042472 | |
| GeneOntologyBiologicalProcess | steroid catabolic process | 1.11e-03 | 34 | 124 | 3 | GO:0006706 | |
| GeneOntologyBiologicalProcess | olefinic compound biosynthetic process | 1.21e-03 | 35 | 124 | 3 | GO:0120255 | |
| GeneOntologyBiologicalProcess | ATF6-mediated unfolded protein response | 1.26e-03 | 9 | 124 | 2 | GO:0036500 | |
| GeneOntologyBiologicalProcess | vitamin metabolic process | 1.26e-03 | 133 | 124 | 5 | GO:0006766 | |
| GeneOntologyBiologicalProcess | response to prostaglandin | 1.31e-03 | 36 | 124 | 3 | GO:0034694 | |
| GeneOntologyBiologicalProcess | isoprenoid biosynthetic process | 1.31e-03 | 36 | 124 | 3 | GO:0008299 | |
| GeneOntologyBiologicalProcess | organelle assembly | EPHB2 MYH6 MYH7 MYH10 DCAF13 SPG11 KLHL41 ATG2A WDR19 ARL6 DOCK7 CFAP74 MYOM2 PRKDC LRBA TNS3 | 1.31e-03 | 1138 | 124 | 16 | GO:0070925 |
| GeneOntologyCellularComponent | myosin filament | 3.41e-07 | 25 | 125 | 5 | GO:0032982 | |
| GeneOntologyCellularComponent | myosin II complex | 2.23e-05 | 28 | 125 | 4 | GO:0016460 | |
| GeneOntologyCellularComponent | myosin complex | 2.73e-05 | 59 | 125 | 5 | GO:0016459 | |
| GeneOntologyCellularComponent | DNA-dependent protein kinase complex | 3.51e-04 | 5 | 125 | 2 | GO:0070418 | |
| Domain | Myosin_N | 2.39e-06 | 15 | 124 | 4 | PF02736 | |
| Domain | Myosin_N | 2.39e-06 | 15 | 124 | 4 | IPR004009 | |
| Domain | Myosin_head_motor_dom | 5.01e-06 | 38 | 124 | 5 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 5.01e-06 | 38 | 124 | 5 | PS51456 | |
| Domain | Myosin_head | 5.01e-06 | 38 | 124 | 5 | PF00063 | |
| Domain | MYSc | 5.01e-06 | 38 | 124 | 5 | SM00242 | |
| Domain | Myosin_tail_1 | 5.27e-06 | 18 | 124 | 4 | PF01576 | |
| Domain | Myosin_tail | 5.27e-06 | 18 | 124 | 4 | IPR002928 | |
| Domain | Myosin-like_IQ_dom | 6.64e-06 | 19 | 124 | 4 | IPR027401 | |
| Domain | - | 6.64e-06 | 19 | 124 | 4 | 4.10.270.10 | |
| Domain | zf-MIZ | 9.80e-06 | 7 | 124 | 3 | PF02891 | |
| Domain | ZF_SP_RING | 9.80e-06 | 7 | 124 | 3 | PS51044 | |
| Domain | Znf_MIZ | 1.56e-05 | 8 | 124 | 3 | IPR004181 | |
| Domain | ALDOKETO_REDUCTASE_1 | 3.31e-05 | 10 | 124 | 3 | PS00798 | |
| Domain | ALDOKETO_REDUCTASE_2 | 3.31e-05 | 10 | 124 | 3 | PS00062 | |
| Domain | ALDOKETO_REDUCTASE_3 | 3.31e-05 | 10 | 124 | 3 | PS00063 | |
| Domain | Aldo/ket_reductase_CS | 3.31e-05 | 10 | 124 | 3 | IPR018170 | |
| Domain | Aldo/keto_reductase | 3.31e-05 | 10 | 124 | 3 | IPR020471 | |
| Domain | - | 1.50e-04 | 16 | 124 | 3 | 3.20.20.100 | |
| Domain | P-loop_NTPase | MYH6 MYH7 MYH10 ERCC6L KIF21A DDX42 PSMC1 SLFN5 UPF1 GFM2 ARL6 NWD2 IGHMBP2 MYH15 MYO15A NLRP13 | 1.56e-04 | 848 | 124 | 16 | IPR027417 |
| Domain | NADP_OxRdtase_dom | 1.81e-04 | 17 | 124 | 3 | IPR023210 | |
| Domain | Aldo_ket_red | 1.81e-04 | 17 | 124 | 3 | PF00248 | |
| Domain | Aldo/ket_red/Kv-b | 1.81e-04 | 17 | 124 | 3 | IPR001395 | |
| Domain | IQ | 3.88e-04 | 93 | 124 | 5 | PS50096 | |
| Domain | SLED | 4.32e-04 | 5 | 124 | 2 | IPR021987 | |
| Domain | SLED | 4.32e-04 | 5 | 124 | 2 | PF12140 | |
| Domain | E1_dh | 6.45e-04 | 6 | 124 | 2 | PF00676 | |
| Domain | DH_E1 | 6.45e-04 | 6 | 124 | 2 | IPR001017 | |
| Domain | - | 8.98e-04 | 7 | 124 | 2 | 3.30.70.240 | |
| Domain | EFG_V | 8.98e-04 | 7 | 124 | 2 | IPR000640 | |
| Domain | Helicase/UvrB_N | 1.19e-03 | 8 | 124 | 2 | IPR006935 | |
| Domain | PH-BEACH_dom | 1.19e-03 | 8 | 124 | 2 | IPR023362 | |
| Domain | - | 1.19e-03 | 8 | 124 | 2 | 2.30.29.40 | |
| Domain | PH_BEACH | 1.19e-03 | 8 | 124 | 2 | PS51783 | |
| Domain | ResIII | 1.19e-03 | 8 | 124 | 2 | PF04851 | |
| Domain | MBT | 1.53e-03 | 9 | 124 | 2 | SM00561 | |
| Domain | MBT | 1.53e-03 | 9 | 124 | 2 | PS51079 | |
| Domain | BEACH | 1.53e-03 | 9 | 124 | 2 | PS50197 | |
| Domain | Beach | 1.53e-03 | 9 | 124 | 2 | PF02138 | |
| Domain | - | 1.53e-03 | 9 | 124 | 2 | 1.10.1540.10 | |
| Domain | Beach | 1.53e-03 | 9 | 124 | 2 | SM01026 | |
| Domain | R3H | 1.53e-03 | 9 | 124 | 2 | SM00393 | |
| Domain | BEACH_dom | 1.53e-03 | 9 | 124 | 2 | IPR000409 | |
| Domain | MBT | 1.90e-03 | 10 | 124 | 2 | PF02820 | |
| Domain | Mbt | 1.90e-03 | 10 | 124 | 2 | IPR004092 | |
| Domain | IQ | 2.08e-03 | 81 | 124 | 4 | SM00015 | |
| Domain | WD40 | 2.10e-03 | 268 | 124 | 7 | SM00320 | |
| Domain | PH_dom-like | 2.16e-03 | 426 | 124 | 9 | IPR011993 | |
| Domain | WD40_repeat | 2.28e-03 | 272 | 124 | 7 | IPR001680 | |
| Domain | R3H | 2.31e-03 | 11 | 124 | 2 | PS51061 | |
| Domain | R3H | 2.31e-03 | 11 | 124 | 2 | PF01424 | |
| Domain | - | 2.31e-03 | 11 | 124 | 2 | 3.30.1370.50 | |
| Domain | R3H_dom | 2.31e-03 | 11 | 124 | 2 | IPR001374 | |
| Domain | WD_REPEATS_1 | 2.57e-03 | 278 | 124 | 7 | PS00678 | |
| Domain | WD_REPEATS_2 | 2.63e-03 | 279 | 124 | 7 | PS50082 | |
| Domain | WD_REPEATS_REGION | 2.63e-03 | 279 | 124 | 7 | PS50294 | |
| Domain | IQ_motif_EF-hand-BS | 3.05e-03 | 90 | 124 | 4 | IPR000048 | |
| Pathway | WP_BENZOAPYRENE_METABOLISM | 1.99e-05 | 9 | 89 | 3 | M39344 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_METALS_TO_KEAP1_NRF2_SIGNALIG_PATHWAY | 1.99e-05 | 9 | 89 | 3 | M47817 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_BENZO_A_PYRENRE_TO_CYP_MEDIATED_METABOLISM | 3.87e-05 | 11 | 89 | 3 | M47812 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_24_HYDROXYCHOLESTEROL | 6.65e-05 | 13 | 89 | 3 | M17842 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_24_HYDROXYCHOLESTEROL | 6.65e-05 | 13 | 89 | 3 | MM14747 | |
| Pathway | WP_GLUCOCORTICOID_BIOSYNTHESIS | 8.42e-05 | 14 | 89 | 3 | M46449 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_27_HYDROXYCHOLESTEROL | 8.42e-05 | 14 | 89 | 3 | M27074 | |
| Pathway | WP_MINERALOCORTICOID_BIOSYNTHESIS | 8.42e-05 | 14 | 89 | 3 | M46453 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_27_HYDROXYCHOLESTEROL | 8.42e-05 | 14 | 89 | 3 | MM14748 | |
| Pathway | REACTOME_SYNTHESIS_OF_PROSTAGLANDINS_PG_AND_THROMBOXANES_TX | 1.05e-04 | 15 | 89 | 3 | MM14870 | |
| Pathway | REACTOME_SIGNALING_BY_RETINOIC_ACID | 2.53e-04 | 49 | 89 | 4 | MM15186 | |
| Pathway | REACTOME_ACTIVATION_OF_RAS_IN_B_CELLS | 3.89e-04 | 5 | 89 | 2 | M26921 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA_HYDROXYCHOLESTEROL | 3.93e-04 | 23 | 89 | 3 | M1926 | |
| Pathway | REACTOME_PREDNISONE_ADME | 3.93e-04 | 23 | 89 | 3 | MM16639 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA_HYDROXYCHOLESTEROL | 3.93e-04 | 23 | 89 | 3 | MM14741 | |
| Pubmed | 4.64e-08 | 3 | 126 | 3 | 19320734 | ||
| Pubmed | Aldo-keto reductases protect metastatic melanoma from ER stress-independent ferroptosis. | 4.64e-08 | 3 | 126 | 3 | 31780644 | |
| Pubmed | 4.64e-08 | 3 | 126 | 3 | 13678667 | ||
| Pubmed | 4.64e-08 | 3 | 126 | 3 | 21232532 | ||
| Pubmed | Timing of adrenal regression controlled by synergistic interaction between Sf1 SUMOylation and Dax1. | 7.95e-08 | 12 | 126 | 4 | 28893949 | |
| Pubmed | Structure and activity of the murine type 5 17beta-hydroxysteroid dehydrogenase gene(1). | 1.85e-07 | 4 | 126 | 3 | 10500239 | |
| Pubmed | 1.85e-07 | 4 | 126 | 3 | 19487289 | ||
| Pubmed | Cloning and chromosomal localization of mouse 20alpha-hydroxysteroid dehydrogenase gene. | 1.85e-07 | 4 | 126 | 3 | 14967952 | |
| Pubmed | 1.85e-07 | 4 | 126 | 3 | 10393440 | ||
| Pubmed | Localization of 20alpha-hydroxysteroid dehydrogenase mRNA in mouse brain by in situ hybridization. | 1.85e-07 | 4 | 126 | 3 | 15193432 | |
| Pubmed | Mouse Akr1cl gene product is a prostaglandin D2 11-ketoreductase with strict substrate specificity. | 1.85e-07 | 4 | 126 | 3 | 31479646 | |
| Pubmed | 1.85e-07 | 4 | 126 | 3 | 16191478 | ||
| Pubmed | 1.85e-07 | 4 | 126 | 3 | 15577209 | ||
| Pubmed | 1.85e-07 | 4 | 126 | 3 | 10702227 | ||
| Pubmed | 1.85e-07 | 4 | 126 | 3 | 17034817 | ||
| Pubmed | RECON-Dependent Inflammation in Hepatocytes Enhances Listeria monocytogenes Cell-to-Cell Spread. | 1.85e-07 | 4 | 126 | 3 | 29764944 | |
| Pubmed | 1.85e-07 | 4 | 126 | 3 | 17888864 | ||
| Pubmed | 1.85e-07 | 4 | 126 | 3 | 17442338 | ||
| Pubmed | 1.85e-07 | 4 | 126 | 3 | 28329705 | ||
| Pubmed | 1.85e-07 | 4 | 126 | 3 | 19237748 | ||
| Pubmed | 1.85e-07 | 4 | 126 | 3 | 28259989 | ||
| Pubmed | 1.85e-07 | 4 | 126 | 3 | 16511129 | ||
| Pubmed | 1.85e-07 | 4 | 126 | 3 | 7789999 | ||
| Pubmed | 1.85e-07 | 4 | 126 | 3 | 20124700 | ||
| Pubmed | Enzymatic properties of a member (AKR1C20) of the aldo-keto reductase family. | 1.85e-07 | 4 | 126 | 3 | 16508162 | |
| Pubmed | 1.85e-07 | 4 | 126 | 3 | 15222881 | ||
| Pubmed | 1.85e-07 | 4 | 126 | 3 | 8482409 | ||
| Pubmed | 1.85e-07 | 4 | 126 | 3 | 17629694 | ||
| Pubmed | 1.85e-07 | 4 | 126 | 3 | 10526179 | ||
| Pubmed | 1.85e-07 | 4 | 126 | 3 | 16018803 | ||
| Pubmed | 1.85e-07 | 4 | 126 | 3 | 17272929 | ||
| Pubmed | Involvement of 20alpha-hydroxysteroid dehydrogenase in the maintenance of pregnancy in mice. | 1.85e-07 | 4 | 126 | 3 | 18667791 | |
| Pubmed | 1.85e-07 | 4 | 126 | 3 | 21521174 | ||
| Pubmed | 1.85e-07 | 4 | 126 | 3 | 8274401 | ||
| Pubmed | 1.85e-07 | 4 | 126 | 3 | 10803568 | ||
| Pubmed | AKR1C1 alleviates LPS‑induced ALI in mice by activating the JAK2/STAT3 signaling pathway. | 1.85e-07 | 4 | 126 | 3 | 34590152 | |
| Pubmed | MYH6 MYH7 MYH10 DCAF13 KIF21A DDX42 CCT2 SPG11 SFMBT2 NARS2 KHSRP LRPPRC TRIM67 SUPT16H MYH15 CFAP74 MYOM2 EIF2AK4 PRKDC TSACC | 2.54e-07 | 1442 | 126 | 20 | 35575683 | |
| Pubmed | Retinaldehyde is a substrate for human aldo-keto reductases of the 1C subfamily. | 4.62e-07 | 5 | 126 | 3 | 21851338 | |
| Pubmed | 4.62e-07 | 5 | 126 | 3 | 15212687 | ||
| Pubmed | Characterization of brain neurons that express enzymes mediating neurosteroid biosynthesis. | 4.62e-07 | 5 | 126 | 3 | 16984997 | |
| Pubmed | 4.62e-07 | 5 | 126 | 3 | 7737980 | ||
| Pubmed | 4.62e-07 | 5 | 126 | 3 | 17872381 | ||
| Pubmed | Mouse 3alpha-hydroxysteroid dehydrogenase mRNA: a marker of lung maturity. | 4.62e-07 | 5 | 126 | 3 | 17064890 | |
| Pubmed | 4.62e-07 | 5 | 126 | 3 | 10672042 | ||
| Pubmed | 4.62e-07 | 5 | 126 | 3 | 38788959 | ||
| Pubmed | 4.62e-07 | 5 | 126 | 3 | 18003893 | ||
| Pubmed | KIF21A SPG11 ATG2A INPP5F BCOR TIAM2 EFR3A WDR19 SULF1 JOSD1 CACNA1G EIF2AK4 | 5.49e-07 | 529 | 126 | 12 | 14621295 | |
| Pubmed | PDHA1 PSMC1 CCT2 ATG2A KHSRP LRPPRC SUPT16H PRKDC RPA3 NSMAF XPOT | 6.05e-07 | 437 | 126 | 11 | 20562859 | |
| Pubmed | 9.21e-07 | 6 | 126 | 3 | 19273550 | ||
| Pubmed | 9.21e-07 | 6 | 126 | 3 | 15471942 | ||
| Pubmed | MEF2 and NR2F2 cooperate to regulate Akr1c14 gene expression in mouse MA-10 Leydig cells. | 9.21e-07 | 6 | 126 | 3 | 26748576 | |
| Pubmed | The Gαq/11-provoked induction of Akr1c18 in murine luteal cells is mediated by phospholipase C. | 9.21e-07 | 6 | 126 | 3 | 29107092 | |
| Pubmed | 9.21e-07 | 6 | 126 | 3 | 15860270 | ||
| Pubmed | 9.21e-07 | 6 | 126 | 3 | 20159969 | ||
| Pubmed | 9.21e-07 | 6 | 126 | 3 | 17122075 | ||
| Pubmed | Decidual prolactin silences the expression of genes detrimental to pregnancy. | 9.21e-07 | 6 | 126 | 3 | 17255200 | |
| Pubmed | 1.38e-06 | 23 | 126 | 4 | 23685333 | ||
| Pubmed | 1.61e-06 | 7 | 126 | 3 | 21126233 | ||
| Pubmed | 1.61e-06 | 7 | 126 | 3 | 22529366 | ||
| Pubmed | 1.61e-06 | 7 | 126 | 3 | 33127481 | ||
| Pubmed | 1.61e-06 | 7 | 126 | 3 | 12562828 | ||
| Pubmed | 1.61e-06 | 7 | 126 | 3 | 26160177 | ||
| Pubmed | Aldo-ketoreductase 1c19 ablation does not affect insulin secretion in murine islets. | 1.61e-06 | 7 | 126 | 3 | 34843575 | |
| Pubmed | 1.61e-06 | 7 | 126 | 3 | 19846565 | ||
| Pubmed | 1.61e-06 | 7 | 126 | 3 | 16337335 | ||
| Pubmed | 2.57e-06 | 8 | 126 | 3 | 33584538 | ||
| Pubmed | 2.57e-06 | 8 | 126 | 3 | 9224647 | ||
| Pubmed | 2.57e-06 | 8 | 126 | 3 | 20837989 | ||
| Pubmed | 2.70e-06 | 27 | 126 | 4 | 23471215 | ||
| Pubmed | The E3 ubiquitin ligase Siah1 regulates adrenal gland organization and aldosterone secretion. | 3.14e-06 | 28 | 126 | 4 | 29212953 | |
| Pubmed | SFMBT1 ZMIZ1 INPP5F BCOR SFMBT2 ZMIZ2 DOCK7 PLEKHA2 LRBA ZKSCAN4 | 3.15e-06 | 418 | 126 | 10 | 34709266 | |
| Pubmed | 3.84e-06 | 9 | 126 | 3 | 33348080 | ||
| Pubmed | MYH10 DCAF13 PDHA1 DDX42 CCT2 UPF1 URB2 KHSRP LRPPRC DOCK7 PRKDC XPOT | 4.82e-06 | 653 | 126 | 12 | 22586326 | |
| Pubmed | Multifaceted Regulation of Akt by Diverse C-Terminal Post-translational Modifications. | 5.38e-06 | 69 | 126 | 5 | 34941261 | |
| Pubmed | Lack of placental neurosteroid alters cortical development and female somatosensory function. | 5.47e-06 | 10 | 126 | 3 | 36313771 | |
| Pubmed | TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions. | MBTPS1 MYH10 PSMC1 CCT2 UPF1 BCOR KHSRP LRPPRC EFNA1 SUPT16H DOCK7 PLEKHA2 EIF2AK4 RPA3 | 6.78e-06 | 922 | 126 | 14 | 27609421 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | MYH10 DCAF13 PDHA1 KIF21A CGAS PSMC1 CCT2 UPF1 URB2 ZBED5 KHSRP LRPPRC METTL13 SUPT16H PRKDC TNS3 XPOT | 8.17e-06 | 1353 | 126 | 17 | 29467282 |
| Pubmed | 9.89e-06 | 37 | 126 | 4 | 21362171 | ||
| Pubmed | 9.97e-06 | 12 | 126 | 3 | 15169892 | ||
| Pubmed | 9.97e-06 | 12 | 126 | 3 | 8424456 | ||
| Pubmed | 9.97e-06 | 12 | 126 | 3 | 25774556 | ||
| Pubmed | Jumonji, a nuclear protein that is necessary for normal heart development. | 9.97e-06 | 12 | 126 | 3 | 10807864 | |
| Pubmed | Endogenous biotin as a marker of adrenocortical cells with steroidogenic potential. | 9.97e-06 | 12 | 126 | 3 | 21256921 | |
| Pubmed | 1.29e-05 | 13 | 126 | 3 | 11682476 | ||
| Pubmed | A link between lung androgen metabolism and the emergence of mature epithelial type II cells. | 1.29e-05 | 13 | 126 | 3 | 15117747 | |
| Pubmed | 1.29e-05 | 13 | 126 | 3 | 34838591 | ||
| Pubmed | 1.29e-05 | 13 | 126 | 3 | 24580729 | ||
| Pubmed | 1.29e-05 | 13 | 126 | 3 | 17062636 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 21526716 | ||
| Pubmed | Importance of the REM (Ras exchange) domain for membrane interactions by RasGRP3. | 1.30e-05 | 2 | 126 | 2 | 28912101 | |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 8573067 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 15492289 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 2726733 | ||
| Pubmed | Human cardiac myosin heavy chain genes and their linkage in the genome. | 1.30e-05 | 2 | 126 | 2 | 3037493 | |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 21778428 | ||
| Pubmed | Structural organization of the human cardiac alpha-myosin heavy chain gene (MYH6). | 1.30e-05 | 2 | 126 | 2 | 8307559 | |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 2969919 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 17575272 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 9884344 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 36574362 | ||
| Interaction | EEF1D interactions | MBTPS1 PDHA1 FOS PSMC1 CCT2 UPF1 KHSRP TRIM67 NFX1 RPA3 VCAM1 | 7.38e-06 | 333 | 125 | 11 | int:EEF1D |
| Interaction | TRMT5 interactions | 1.17e-05 | 48 | 125 | 5 | int:TRMT5 | |
| Interaction | AKR1C4 interactions | 1.28e-05 | 8 | 125 | 3 | int:AKR1C4 | |
| Interaction | DSP interactions | WSB1 RIN3 DCAF13 CDKL2 PDHA1 CASP4 CCT2 EFNA1 TRIM67 PRKDC RPA3 GAB1 | 1.30e-05 | 423 | 125 | 12 | int:DSP |
| Interaction | ATPAF1 interactions | 1.51e-05 | 128 | 125 | 7 | int:ATPAF1 | |
| Interaction | VTA1 interactions | 2.35e-05 | 137 | 125 | 7 | int:VTA1 | |
| Interaction | CLCA1 interactions | 2.71e-05 | 10 | 125 | 3 | int:CLCA1 | |
| Interaction | BABAM2 interactions | 2.79e-05 | 95 | 125 | 6 | int:BABAM2 | |
| Cytoband | 10p15-p14 | 4.01e-07 | 6 | 126 | 3 | 10p15-p14 | |
| Cytoband | 15q14 | 3.39e-04 | 49 | 126 | 3 | 15q14 | |
| GeneFamily | Myosin heavy chains | 6.56e-07 | 15 | 87 | 4 | 1098 | |
| GeneFamily | Zinc fingers MIZ-type | 3.71e-06 | 7 | 87 | 3 | 85 | |
| GeneFamily | Aldo-keto reductases | 4.70e-05 | 15 | 87 | 3 | 399 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 4.77e-04 | 206 | 87 | 6 | 682 | |
| GeneFamily | SPOUT methyltranferase domain containing | 6.29e-04 | 8 | 87 | 2 | 1294 | |
| GeneFamily | Sterile alpha motif domain containing|MBT domain containing | 8.06e-04 | 9 | 87 | 2 | 1263 | |
| GeneFamily | WD repeat domain containing|BEACH domain containing | 8.06e-04 | 9 | 87 | 2 | 1230 | |
| GeneFamily | UPF1 like RNA helicases | 1.22e-03 | 11 | 87 | 2 | 1169 | |
| GeneFamily | WD repeat domain containing | 1.66e-03 | 262 | 87 | 6 | 362 | |
| Coexpression | VARELA_ZMPSTE24_TARGETS_DN | 2.48e-06 | 45 | 126 | 5 | MM1173 | |
| Coexpression | LIN_TUMOR_ESCAPE_FROM_IMMUNE_ATTACK | 5.02e-06 | 24 | 126 | 4 | MM766 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.16e-08 | 190 | 126 | 8 | 32400c62cb9de4c2b24af4206c21a0215ab12212 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS-Exc_L5-6_THEMIS_GPR21|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.89e-07 | 182 | 126 | 7 | 1647367b75b4b107af06bb934394168230cfd7c2 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial-lymphatic_endothelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.22e-07 | 183 | 126 | 7 | 764ea07621f77fbd13a877aed5806ae2b3dfb43e | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.22e-07 | 183 | 126 | 7 | 38a54216458ad57f356bb4ddf272e1af8036ddeb | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.14e-06 | 189 | 126 | 7 | 0739baad9a7da511dd3d7249f84299aee88370a1 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.18e-06 | 190 | 126 | 7 | b2bd2cb384bb8a5662064ed1aee68e905e1f780d | |
| ToppCell | P03-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.27e-06 | 192 | 126 | 7 | 2802fae55683345ff94a1ecf73b6fbee4f17481e | |
| ToppCell | P03-Mesenchymal-mesenchymal_fibroblast|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.27e-06 | 192 | 126 | 7 | e79f2253e084a9ab9afcaf7ec42a5012ade42d36 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l1|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.72e-06 | 157 | 126 | 6 | 1f21d78a467fe22c5ab75d0917b840c1ac93f32c | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_B-B_plasma-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.03e-05 | 174 | 126 | 6 | bdbaf805a94b2f5a0065933dab6bf84e3cabd525 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS-Exc_L5-6_THEMIS_GPR21|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.10e-05 | 176 | 126 | 6 | 03d194c9814e12802cd932afade69e868814cb78 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.10e-05 | 176 | 126 | 6 | 327a3e81b724252e36d786de92a3ffd721ea6d7b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.25e-05 | 180 | 126 | 6 | 7a9aa96fb8035020640cc7d3df0c41c730516c6f | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.29e-05 | 181 | 126 | 6 | 13270b6ba6a9c8e5681c6f40000c643ce1d9344a | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS-Exc_L5-6_THEMIS_IL7R|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.29e-05 | 181 | 126 | 6 | 3e3c903b522dced6bec5dc447cc3f8bf9a9749e3 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.29e-05 | 181 | 126 | 6 | b7c85fbef3c06d5dc32a2a58f8d3dfabf1d79d9f | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma-2|TCGA-Skin / Sample_Type by Project: Shred V9 | 1.29e-05 | 181 | 126 | 6 | 9d5b331cabc5524f0a9fd8b571e87be4c447c7d4 | |
| ToppCell | P28-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.33e-05 | 182 | 126 | 6 | 19c5e3a9d9b3728303b682102e276adfe93aa759 | |
| ToppCell | facs-Lung-18m-Endothelial-arterial_endothelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.33e-05 | 182 | 126 | 6 | ebc812ed3f25839ea25f76b952c463d79a8325b1 | |
| ToppCell | facs-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.33e-05 | 182 | 126 | 6 | 47ff6b4002a4167412c79210651316d1342503f9 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.37e-05 | 183 | 126 | 6 | 738e94b50c4c08c727d4eed0708dda08aa6891b4 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-05 | 184 | 126 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | droplet-Lung-nan-3m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-05 | 184 | 126 | 6 | 89ac32e374a4379e4a6c6ea7603b1378b77c147f | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-05 | 184 | 126 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-05 | 184 | 126 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | droplet-Lung-nan-3m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-05 | 184 | 126 | 6 | 4df6027fa635996c1eddb920f88a5265772df1cd | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial-LEC5_(CLDN11+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.46e-05 | 185 | 126 | 6 | 241ea1e178fffef9e7df971de739e794332d5173 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.50e-05 | 186 | 126 | 6 | 5302399825f213d105ac70b91366a4513b732838 | |
| ToppCell | COVID-19-kidney-tDL|kidney / Disease (COVID-19 only), tissue and cell type | 1.55e-05 | 187 | 126 | 6 | d35d27ca3c0e65f92f4508e1cb98a743f44fdcdf | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 1.55e-05 | 187 | 126 | 6 | 78cdcf8bc141d3b155c3c8af908431fc419c4d08 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.60e-05 | 188 | 126 | 6 | 58ccb31cdf43167872ef0fc737e6f9c51ee2e060 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.65e-05 | 189 | 126 | 6 | c9565e962a13a7713056ec3dbb1b67d24f9889c7 | |
| ToppCell | wk_20-22-Endothelial-Lymph_endothelial-Intermediate_lymphatic_endo|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.70e-05 | 190 | 126 | 6 | 103e78c2233c3ee0c215a9dafe70705477e9ee5e | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-alveolar_fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.75e-05 | 191 | 126 | 6 | 509230f50568e5a8ecf08edc4d58f9e2aa96efe9 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.75e-05 | 191 | 126 | 6 | a261f0738d974784bbdd60f23092bfbcca464459 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.75e-05 | 191 | 126 | 6 | d0e9afe7b6334dd515d3e68892efdc76347a55e5 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.75e-05 | 191 | 126 | 6 | 6594398cc8151c73696391a43ac110c10283dab1 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.75e-05 | 191 | 126 | 6 | 0b3dbbc35d9970d3c749aef16dda59886b960e3d | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Endothelial-lymphatic_endothelial|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.80e-05 | 192 | 126 | 6 | fa0ef05a32c661bdd59b5a9b6f75fd647ee937f3 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.80e-05 | 192 | 126 | 6 | 25492568f9cbe097b7bb1db50d8b817c80ea87d7 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.80e-05 | 192 | 126 | 6 | 5388f3115ab285f3f3001af1d71543ed64b9e044 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.80e-05 | 192 | 126 | 6 | 4e63d95f75fe6eb3f817e84528883e95093c5bbd | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.80e-05 | 192 | 126 | 6 | de9c1536d5aee86f9c62acbc54ca8fa581c00f17 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.85e-05 | 193 | 126 | 6 | ef007b736da56529ec628fc3df86a335e7ec3f18 | |
| ToppCell | E17.5-Mesenchymal-mesenchymal_fibroblast|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.91e-05 | 194 | 126 | 6 | f15e81ff12525523c62d13105cf264ea72205e2e | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.96e-05 | 195 | 126 | 6 | 3a0cad69cfc150a27a0666f612f5294c817197d7 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.96e-05 | 195 | 126 | 6 | 2b8ee7990267bb52b7e6ae03f509ffebf8908122 | |
| ToppCell | P03-Mesenchymal|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.96e-05 | 195 | 126 | 6 | 6180309c6ae278b996fd98c57461cbc129c028ba | |
| ToppCell | E17.5-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.96e-05 | 195 | 126 | 6 | b072fdc2131173f562e55dd78226eaf2c57d3690 | |
| ToppCell | 10x3'2.3-week_14-16-Hematopoietic-erythroid-early_erythroid|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.14e-05 | 198 | 126 | 6 | 36c848b747903ff875ebb241eefbcd889f39be29 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Perivascular_fibroblast|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.20e-05 | 199 | 126 | 6 | dfc5c7a4a093baa7158dd8d4d29a870d9c469a3f | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Perivascular_fibroblast-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.20e-05 | 199 | 126 | 6 | c1760581c34b81d1d92c67500a1c8944e9cc6dad | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-Mesenchymal-BMP_responsible_cell|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 2.26e-05 | 200 | 126 | 6 | cd0d69f973ca3204b500d12031b403a1f4593431 | |
| ToppCell | mLN-Macrophage-LYVE1_Macrophage|Macrophage / Region, Cell class and subclass | 2.26e-05 | 200 | 126 | 6 | e3c15e0e1c2602b0cc9ab8cc50c978d265350c94 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Mesenchymal|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 2.26e-05 | 200 | 126 | 6 | fe22f7c97f4e37dfa7881d0f1d9245c1237d873b | |
| ToppCell | Neuronal-Excitatory-eH(THEMIS)-CRABP1-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.26e-05 | 200 | 126 | 6 | 473e85930f433e392956a7a10ea5d09fdc2a35b1 | |
| ToppCell | Neuronal-Excitatory-eH(THEMIS)-CRABP1--|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.26e-05 | 200 | 126 | 6 | 73b7e395398fdc9aa5adb3ade675ae0168d7f46c | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-Mesenchymal|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 2.26e-05 | 200 | 126 | 6 | 16caefcc5bdca82d904462c6fd0ffa80d96fa474 | |
| ToppCell | Neuronal-Excitatory-eH(THEMIS)-CRABP1---L5-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.26e-05 | 200 | 126 | 6 | c9113e7a9624499db3e66c01462159e8e8781cc4 | |
| ToppCell | Neuronal-Excitatory-eH(THEMIS)-CRABP1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.26e-05 | 200 | 126 | 6 | a737c4f535723e389ba4b957ae1fdc5162d3d951 | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Pi16_(Pi16)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 5.24e-05 | 142 | 126 | 5 | 58bfff3284ae21150e4619511bd58622c16c5dde | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Pi16_(Pi16)--|Thalamus / BrainAtlas - Mouse McCarroll V32 | 5.24e-05 | 142 | 126 | 5 | 5fd737c1fee9d97aee8955f1bf378ead3fce138d | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Pi16_(Pi16)-|Thalamus / BrainAtlas - Mouse McCarroll V32 | 5.24e-05 | 142 | 126 | 5 | 16f9945e835c3506b12d904778560d065a50f059 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-intermediate_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.42e-05 | 143 | 126 | 5 | 4d11d53330a9197275a8851e1bbf55a113715a09 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-Intermediate_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.42e-05 | 143 | 126 | 5 | 8b9f4d87d5faac7752c83e1992491fc5550600f8 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Dendritic-plasmacytoid_dendritic_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.44e-05 | 157 | 126 | 5 | ffb8dd381e6b9adc5283fb49586e8bd63773c8d6 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Dendritic-plasmacytoid_dendritic_cell-DC_c4-LILRA4|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.44e-05 | 157 | 126 | 5 | c488ab1d6c6c7e5c2f4426805d1366b44711a031 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c09-GZMK-FOS_l|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.96e-05 | 159 | 126 | 5 | 03d77e7fee40262bf0942aab96b273f1c4f5d8e3 | |
| ToppCell | TCGA-Bladder-Solid_Tissue_Normal-Urothelial_normal_tissue-Urothelial_normal_tissue|TCGA-Bladder / Sample_Type by Project: Shred V9 | 9.22e-05 | 160 | 126 | 5 | 8a41e2c96e0e170ac35daf6c403bf961b8d7c30b | |
| ToppCell | TCGA-Bladder-Solid_Tissue_Normal|TCGA-Bladder / Sample_Type by Project: Shred V9 | 9.22e-05 | 160 | 126 | 5 | d6678996e12eaf2b735f1dfae32418cb2fabf268 | |
| ToppCell | TCGA-Bladder-Solid_Tissue_Normal-Urothelial_normal_tissue|TCGA-Bladder / Sample_Type by Project: Shred V9 | 9.22e-05 | 160 | 126 | 5 | c8dc575562b463fd30832d322c28006f18f7ab9c | |
| ToppCell | P07-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 9.50e-05 | 161 | 126 | 5 | b19f82dd98a3064581793711bb70373f18abecd9 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.78e-05 | 162 | 126 | 5 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-04 | 165 | 126 | 5 | 6d315e0734079ad05336cc2c3f24d870c9105bc8 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-04 | 165 | 126 | 5 | 84f5597b1bb75f42de9a224196bb8ac198bbe3bf | |
| ToppCell | Control-Epithelial-Mesothelial|World / Disease state, Lineage and Cell class | 1.10e-04 | 166 | 126 | 5 | 32ebaefa6c074b28193fff764ee7c2c0e9357e20 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Endothelial-lymphatic_endothelial|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.10e-04 | 166 | 126 | 5 | 941d6aa94ab9d36e5f6c40f446c926754e070d56 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.10e-04 | 166 | 126 | 5 | 6f5ecf3b2cf613ae0535ab3d21d93622f1497571 | |
| ToppCell | Control-Epithelial-Mesothelial|Control / Disease state, Lineage and Cell class | 1.10e-04 | 166 | 126 | 5 | 1ed3788257e14f097862b999f020bfe2a57de52b | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-04 | 169 | 126 | 5 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.23e-04 | 170 | 126 | 5 | 928e42c51a7079c506f21c669c4e4c1a0df84d77 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L5-6_THEMIS_TMEM233|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.26e-04 | 171 | 126 | 5 | fdd96c6fe850bd10e1e0d0f18c4401f8348b7d2c | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.30e-04 | 172 | 126 | 5 | cecfe5cf20f317ea01b4604789e07a14481c4cd6 | |
| ToppCell | PND01-03-samps-Endothelial-Postnatal_endothelial-endothelial_cells_D|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 1.37e-04 | 174 | 126 | 5 | b4f3f5334803e5903bc496decf923f2e44f7fa3c | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS-Exc_L5-6_THEMIS_GPR21|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.37e-04 | 174 | 126 | 5 | 0df738309b7b6e77675ea74e7a87e66601b0073d | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.37e-04 | 174 | 126 | 5 | 9d22a554617a93701d0945de63cc3e7b24322c40 | |
| ToppCell | P15-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.37e-04 | 174 | 126 | 5 | 3c47d069bd836599a8d40eae485c23d4d3487517 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Ccr7+_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-04 | 175 | 126 | 5 | 91cb819a1786020713b7e64480de0545380daae9 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_IT|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.40e-04 | 175 | 126 | 5 | c227fc5d1ccb69b82a96a6354913cafaf27d0eec | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_B_plasma-Plasma_cells|bone_marrow / Manually curated celltypes from each tissue | 1.40e-04 | 175 | 126 | 5 | 51301f3f44d3e88397f367cedd1e2abaa2be4c6f | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.44e-04 | 176 | 126 | 5 | 0710689e66deba179b0a8038cdd56b4834984f12 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.44e-04 | 176 | 126 | 5 | cb8fd56a4f935cdda19d7ab43382cdda7c307667 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-04 | 176 | 126 | 5 | 5e46a09a36b9645b1b1fcb0b64bd0898561af3a9 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.48e-04 | 177 | 126 | 5 | 64fbf799e7b0c4003b2f486cc41b0f7e7c11ea0c | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.48e-04 | 177 | 126 | 5 | da8802a6351d3e510822f82e2fde8a4314a2216e | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.48e-04 | 177 | 126 | 5 | f30d757ee8db7e10d547498dab6560473c6ed7c0 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_1-Mesothelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.48e-04 | 177 | 126 | 5 | 0912a291cff32a4ff8a2d7680ed1a1cd867fb90f | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.52e-04 | 178 | 126 | 5 | b169aa5eaa51730daaec69c6bc58126be1592a50 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c05-MZB1-XBP1|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.52e-04 | 178 | 126 | 5 | 6765c6970b1f2b719a20d2afd7471e1c262f3fc4 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_B-Plasma_cell|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.52e-04 | 178 | 126 | 5 | 693f1135d9c5545945e80c7ba3d098afc0ccac29 | |
| Drug | cyclopentanol | 1.62e-07 | 3 | 125 | 3 | ctd:C016327 | |
| Drug | cyclopentanone | 1.62e-07 | 3 | 125 | 3 | ctd:C007201 | |
| Drug | 4-benzoylbenzoic acid | 1.62e-07 | 3 | 125 | 3 | ctd:C058818 | |
| Drug | dichloro(4-cymene)ruthenium(II) | 1.62e-07 | 3 | 125 | 3 | ctd:C530610 | |
| Drug | cloxazolam | 6.44e-07 | 4 | 125 | 3 | ctd:C005522 | |
| Drug | Pregnanes | 6.44e-07 | 4 | 125 | 3 | ctd:D011278 | |
| Drug | tetralol | 6.44e-07 | 4 | 125 | 3 | ctd:C019106 | |
| Drug | gliquidone | 6.44e-07 | 4 | 125 | 3 | ctd:C010969 | |
| Drug | 3',3'',5',5''-tetrabromophenolphthalein | 6.44e-07 | 4 | 125 | 3 | ctd:C018156 | |
| Drug | Hydroxysteroids | 1.60e-06 | 5 | 125 | 3 | ctd:D006914 | |
| Drug | NSC86000 | 1.60e-06 | 5 | 125 | 3 | CID000257630 | |
| Drug | cresolphthalein | 1.60e-06 | 5 | 125 | 3 | ctd:C010092 | |
| Drug | Estazolam | 3.19e-06 | 6 | 125 | 3 | ctd:D004949 | |
| Drug | Glipizide | 3.19e-06 | 6 | 125 | 3 | ctd:D005913 | |
| Drug | acenaphthene-1-ol | 3.19e-06 | 6 | 125 | 3 | ctd:C023723 | |
| Drug | Medazepam | 3.19e-06 | 6 | 125 | 3 | ctd:D008472 | |
| Drug | Dutasteride | 4.82e-06 | 21 | 125 | 4 | ctd:D000068538 | |
| Drug | 4-hydroxyequilenin-o-quinone | 5.56e-06 | 7 | 125 | 3 | ctd:C117714 | |
| Drug | zomepirac | 5.56e-06 | 7 | 125 | 3 | ctd:C020549 | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 7.28e-06 | 181 | 125 | 8 | 6951_DN | |
| Drug | Nitrazepam | 8.87e-06 | 8 | 125 | 3 | ctd:D009567 | |
| Drug | Air Pollutants | WSB1 CDKL2 FOS PDZK1 CASP4 SPG11 SLFN5 TGFA WDR19 EFNA1 ENTPD5 HINT3 HABP2 PRKDC LRBA VCAM1 GAB1 | 1.12e-05 | 917 | 125 | 17 | ctd:D000393 |
| Drug | 4-hydroxybenzoic acid | 1.32e-05 | 9 | 125 | 3 | ctd:C038193 | |
| Drug | 20-alpha-Dihydroprogesterone | 1.32e-05 | 9 | 125 | 3 | ctd:D004092 | |
| Drug | octyl gallate | 1.88e-05 | 10 | 125 | 3 | ctd:C016627 | |
| Drug | Dihydroxydihydrobenzopyrenes | 2.58e-05 | 11 | 125 | 3 | ctd:D004101 | |
| Drug | chlordecone alcohol | 2.58e-05 | 11 | 125 | 3 | CID000013946 | |
| Drug | alpha-methylcinnamic acid | 2.99e-05 | 2 | 125 | 2 | ctd:C510582 | |
| Drug | (10ALPHA,13ALPHA,14BETA,17ALPHA)-17-HYDROXYANDROST-4-EN-3-ONE | 2.99e-05 | 2 | 125 | 2 | DB07768 | |
| Drug | baccharin | 2.99e-05 | 2 | 125 | 2 | ctd:C012764 | |
| Drug | homocysteic acid | 3.15e-05 | 66 | 125 | 5 | CID000092117 | |
| Drug | fenamic acid | 3.43e-05 | 12 | 125 | 3 | ctd:C001209 | |
| Drug | Phenolphthalein | 3.43e-05 | 12 | 125 | 3 | ctd:D020113 | |
| Drug | DMBA-3,4-dihydrodiol | 4.44e-05 | 13 | 125 | 3 | CID000050096 | |
| Drug | flunisolide | 4.44e-05 | 13 | 125 | 3 | ctd:C007734 | |
| Drug | SAHA; Down 200; 10uM; MCF7; HT_HG-U133A | 5.62e-05 | 177 | 125 | 7 | 1645_DN | |
| Drug | Dydrogesterone | 5.63e-05 | 14 | 125 | 3 | ctd:D004394 | |
| Drug | 5-alpha-Dihydroprogesterone | 5.63e-05 | 14 | 125 | 3 | ctd:D043582 | |
| Drug | 1-acenaphthenol | 5.63e-05 | 14 | 125 | 3 | CID000022750 | |
| Drug | Meclofenamic Acid | 5.63e-05 | 14 | 125 | 3 | ctd:D008469 | |
| Drug | Piperlongumine [20069-09-4]; Down 200; 12.6uM; HL60; HG-U133A | 6.03e-05 | 179 | 125 | 7 | 1764_DN | |
| Drug | Propofol [2078-54-8]; Up 200; 22.4uM; MCF7; HT_HG-U133A | 7.95e-05 | 187 | 125 | 7 | 3386_UP | |
| Drug | Niclosamide [50-65-7]; Down 200; 12.2uM; HL60; HG-U133A | 8.22e-05 | 188 | 125 | 7 | 1998_DN | |
| Drug | 5-dihydrodeoxycorticosterone | 8.94e-05 | 3 | 125 | 2 | ctd:C454687 | |
| Drug | Homosalate [118-56-9]; Down 200; 15.2uM; PC3; HT_HG-U133A | 1.03e-04 | 195 | 125 | 7 | 4533_DN | |
| Drug | Diperodon hydrochloride [537-12-2]; Up 200; 9.2uM; HL60; HG-U133A | 1.03e-04 | 195 | 125 | 7 | 1575_UP | |
| Drug | benzo(a)pyrene-1,6-quinone | 1.04e-04 | 17 | 125 | 3 | ctd:C030233 | |
| Drug | Pepstatin A [26305-03-3]; Down 200; 5.8uM; PC3; HT_HG-U133A | 1.07e-04 | 196 | 125 | 7 | 4206_DN | |
| Drug | 2-propylpentanoic acid; Up 200; 1000uM; PC3; HG-U133A | 1.10e-04 | 197 | 125 | 7 | 458_UP | |
| Drug | cloxazolam | 1.24e-04 | 18 | 125 | 3 | CID000002816 | |
| Drug | Ruthenium Compounds | 1.24e-04 | 18 | 125 | 3 | ctd:D017975 | |
| Drug | benzo(a)pyrene-3,6-quinone | 1.24e-04 | 18 | 125 | 3 | ctd:C018003 | |
| Drug | oxcarbazepine | 1.47e-04 | 19 | 125 | 3 | ctd:C036006 | |
| Drug | AC1L419E | 1.47e-04 | 19 | 125 | 3 | CID000099951 | |
| Drug | wartmannin | MYH6 MBTPS1 MYH7 MYH10 FOS UPF1 TGFA PIK3C2G PLEKHA2 PRKDC LRBA MYO15A VCAM1 GAB1 | 1.49e-04 | 811 | 125 | 14 | CID000005691 |
| Drug | benzo(a)pyrene-7,8-dione | 1.72e-04 | 20 | 125 | 3 | ctd:C076588 | |
| Drug | Chrysenes | 1.72e-04 | 20 | 125 | 3 | ctd:D002911 | |
| Drug | formycin triphosphate | 1.77e-04 | 51 | 125 | 4 | CID000122274 | |
| Drug | fenofibric acid | 1.77e-04 | 51 | 125 | 4 | ctd:C006012 | |
| Drug | AC1L1GMQ | 1.78e-04 | 4 | 125 | 2 | CID000003751 | |
| Drug | tetrahydrodeoxycorticosterone | 1.78e-04 | 4 | 125 | 2 | ctd:C009413 | |
| Drug | DBD-H | 1.78e-04 | 4 | 125 | 2 | CID000131382 | |
| Drug | Daunorubicin | 1.94e-04 | 216 | 125 | 7 | ctd:D003630 | |
| Drug | AC1L1KC5 | MBTPS1 CDKL2 WFS1 FOS CASP4 TRIM39 GRM4 PIK3C2G CACNA1G LRBA RPA3 | 1.99e-04 | 541 | 125 | 11 | CID000005428 |
| Drug | Flunitrazepam | 2.00e-04 | 21 | 125 | 3 | ctd:D005445 | |
| Drug | coniferaldehyde | 2.00e-04 | 21 | 125 | 3 | ctd:C075384 | |
| Disease | Neoplasms, Hormone-Dependent | 6.90e-08 | 3 | 122 | 3 | C0027661 | |
| Disease | Hermaphroditism | 6.85e-07 | 5 | 122 | 3 | C0019269 | |
| Disease | Ambiguous Genitalia | 6.85e-07 | 5 | 122 | 3 | C0266362 | |
| Disease | Pseudohermaphroditism | 6.85e-07 | 5 | 122 | 3 | C0033804 | |
| Disease | Intersex Conditions | 6.85e-07 | 5 | 122 | 3 | C2930618 | |
| Disease | Sex Differentiation Disorders | 6.85e-07 | 5 | 122 | 3 | C2930619 | |
| Disease | Disorders of Sex Development | 2.38e-06 | 7 | 122 | 3 | C0036875 | |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 8.10e-06 | 10 | 122 | 3 | DOID:0111269 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 8.10e-06 | 10 | 122 | 3 | DOID:0111602 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 8.10e-06 | 10 | 122 | 3 | DOID:0111596 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 8.10e-06 | 10 | 122 | 3 | DOID:0110454 (implicated_via_orthology) | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 8.10e-06 | 10 | 122 | 3 | DOID:0080719 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 8.10e-06 | 10 | 122 | 3 | DOID:3429 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 8.10e-06 | 10 | 122 | 3 | DOID:0111605 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 8.10e-06 | 10 | 122 | 3 | DOID:0080326 (implicated_via_orthology) | |
| Disease | distal myopathy (implicated_via_orthology) | 1.48e-05 | 12 | 122 | 3 | DOID:11720 (implicated_via_orthology) | |
| Disease | myotonia congenita (implicated_via_orthology) | 1.48e-05 | 12 | 122 | 3 | DOID:2106 (implicated_via_orthology) | |
| Disease | Leigh Syndrome due to Mitochondrial Complex V Deficiency | 1.48e-05 | 36 | 122 | 4 | C1850600 | |
| Disease | Necrotizing encephalopathy, infantile subacute, of Leigh | 1.48e-05 | 36 | 122 | 4 | C2931891 | |
| Disease | Leigh Syndrome due to Mitochondrial Complex III Deficiency | 1.48e-05 | 36 | 122 | 4 | C1850598 | |
| Disease | Leigh Syndrome Due To Mitochondrial Complex II Deficiency | 1.48e-05 | 36 | 122 | 4 | C1850597 | |
| Disease | Leigh Syndrome due to Mitochondrial Complex IV Deficiency | 1.48e-05 | 36 | 122 | 4 | C1850599 | |
| Disease | LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX I DEFICIENCY | 1.65e-05 | 37 | 122 | 4 | C1838951 | |
| Disease | Obstruction of pelviureteric junction | 1.70e-05 | 2 | 122 | 2 | C0521619 | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 1.91e-05 | 13 | 122 | 3 | DOID:397 (implicated_via_orthology) | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 3.03e-05 | 15 | 122 | 3 | DOID:0050646 (implicated_via_orthology) | |
| Disease | Leigh Disease | 4.32e-05 | 47 | 122 | 4 | C0023264 | |
| Disease | Cardiomyopathy, Familial Hypertrophic, 1 (disorder) | 1.01e-04 | 4 | 122 | 2 | C3495498 | |
| Disease | Hypertrophic cardiomyopathy 1 | 1.01e-04 | 4 | 122 | 2 | cv:C3495498 | |
| Disease | Caveolinopathy | 1.01e-04 | 4 | 122 | 2 | cv:C5679790 | |
| Disease | CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1 | 1.01e-04 | 4 | 122 | 2 | 192600 | |
| Disease | cortolone glucuronide (1) measurement | 2.52e-04 | 6 | 122 | 2 | EFO_0800552 | |
| Disease | Neoplastic Cell Transformation | 2.88e-04 | 139 | 122 | 5 | C0007621 | |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 3.45e-04 | 80 | 122 | 4 | DOID:12930 (implicated_via_orthology) | |
| Disease | Idiopathic hypertrophic subaortic stenosis | 3.51e-04 | 7 | 122 | 2 | C0700053 | |
| Disease | Obstructive asymmetric septal hypertrophy | 3.51e-04 | 7 | 122 | 2 | C0597124 | |
| Disease | Hereditary hearing loss and deafness | 3.61e-04 | 146 | 122 | 5 | cv:C0236038 | |
| Disease | Nerve Degeneration | 3.97e-04 | 83 | 122 | 4 | C0027746 | |
| Disease | Leigh syndrome | 4.67e-04 | 8 | 122 | 2 | cv:C0023264 | |
| Disease | opioid dependence | 4.69e-04 | 237 | 122 | 6 | EFO_0005611 | |
| Disease | Endometrioma | 5.64e-04 | 161 | 122 | 5 | C0269102 | |
| Disease | Endometriosis | 5.64e-04 | 161 | 122 | 5 | C0014175 | |
| Disease | Cardiomyopathy, Hypertrophic, Familial | 5.99e-04 | 9 | 122 | 2 | C0949658 | |
| Disease | response to clopidogrel, response to acetylsalicylate, major adverse cardiovascular event measurement | 5.99e-04 | 9 | 122 | 2 | EFO_0020863, GO_1903492, GO_1903493 | |
| Disease | diffusing capacity of the lung for carbon monoxide | 6.89e-04 | 96 | 122 | 4 | EFO_0009369 | |
| Disease | Muscular dystrophy, limb-girdle, autosomal dominant | 7.47e-04 | 10 | 122 | 2 | cv:C5675009 | |
| Disease | alpha angle measurement | 9.10e-04 | 11 | 122 | 2 | EFO_0020071 | |
| Disease | myopathy (implicated_via_orthology) | 1.04e-03 | 48 | 122 | 3 | DOID:423 (implicated_via_orthology) | |
| Disease | Hereditary Diffuse Gastric Cancer | 1.41e-03 | 293 | 122 | 6 | C1708349 | |
| Disease | autosomal dominant polycystic kidney disease (is_marker_for) | 1.49e-03 | 14 | 122 | 2 | DOID:898 (is_marker_for) | |
| Disease | Stomach Neoplasms | 1.51e-03 | 297 | 122 | 6 | C0038356 | |
| Disease | Malignant neoplasm of stomach | 1.58e-03 | 300 | 122 | 6 | C0024623 | |
| Disease | Libman-Sacks Disease | 1.80e-03 | 58 | 122 | 3 | C0242380 | |
| Disease | response to methotrexate | 1.96e-03 | 16 | 122 | 2 | GO_0031427 | |
| Disease | thyroxine measurement, triiodothyronine measurement | 2.21e-03 | 17 | 122 | 2 | EFO_0005130, EFO_0008392 | |
| Disease | chronic obstructive pulmonary disease | 2.28e-03 | 688 | 122 | 9 | EFO_0000341 | |
| Disease | cigarettes per day measurement | 2.35e-03 | 438 | 122 | 7 | EFO_0006525 | |
| Disease | caudal middle frontal gyrus volume measurement | 2.48e-03 | 18 | 122 | 2 | EFO_0010290 | |
| Disease | Sclerocystic Ovaries | 3.06e-03 | 144 | 122 | 4 | C1136382 | |
| Disease | Polycystic Ovary Syndrome | 3.06e-03 | 144 | 122 | 4 | C0032460 | |
| Disease | Lupus Erythematosus, Systemic | 3.21e-03 | 71 | 122 | 3 | C0024141 | |
| Disease | cardiomyopathy (implicated_via_orthology) | 3.21e-03 | 71 | 122 | 3 | DOID:0050700 (implicated_via_orthology) | |
| Disease | cognitive function measurement, self reported educational attainment | 3.65e-03 | 355 | 122 | 6 | EFO_0004784, EFO_0008354 | |
| Disease | Primary familial hypertrophic cardiomyopathy | 3.71e-03 | 22 | 122 | 2 | cv:C0949658 | |
| Disease | Nonsyndromic genetic hearing loss | 3.89e-03 | 76 | 122 | 3 | cv:C5680182 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TRLCHVLGPFLKEQK | 1061 | Q14146 | |
| EEEKRCLLKLPAQAH | 706 | Q8TDY4 | |
| LKAILLHCGIPEDKL | 1206 | Q9P2K8 | |
| CLRLHGITKGKDLEV | 326 | Q32M84 | |
| LEDPVLCALAKKHKR | 236 | P42330 | |
| LKLCPHEEFLRLCKE | 106 | P49662 | |
| HACPEVLLKDETKRI | 191 | B1ANY3 | |
| PCGELKKEKGIHRLE | 66 | Q14833 | |
| LVKAKGEELHCRLID | 156 | O95267 | |
| ECTDFKIPILGVHLK | 346 | O95267 | |
| KAPLRLHSEKPECRI | 641 | Q9NR61 | |
| CEPGQVRAHLRLDKK | 526 | Q8N302 | |
| LGLKKKEVHVLCLGL | 11 | Q9H0F7 | |
| KKHDFAIIRVEELCP | 826 | Q96HY7 | |
| VCIELTGLHPKKQRH | 1196 | Q6W2J9 | |
| VKGVVDHLLLRLKCD | 186 | Q8N884 | |
| RDGVNCLAKHPEKLA | 66 | Q9NV06 | |
| ILGHLDARKKDAPRV | 296 | Q14156 | |
| ELKLKRLCCRHGLLG | 1706 | Q2TAZ0 | |
| PKLRHLLLECDKDGP | 926 | Q9ULI1 | |
| KACGITDLKKHPERE | 566 | Q6ZP01 | |
| LEEPLKECIKHIARL | 646 | O75747 | |
| NSADLLKGLCHPRVK | 391 | P12883 | |
| EVDHKPKLCRLAKGE | 371 | Q5T2W1 | |
| AGLRLLPEHKAKALL | 131 | O75356 | |
| LVVLLCGKKHLGDRL | 11 | Q14703 | |
| EKLEFILAAHRPACK | 191 | P01100 | |
| KRVLKCDVHLGNPLA | 136 | O95050 | |
| LPGGLERHLKIKTCT | 3216 | Q9UKN7 | |
| DHAKKPIRIIDLNLC | 51 | Q13480 | |
| LREDKKCPGSLHIIR | 71 | Q8N7B1 | |
| LVVPKKHIGNCRTLR | 86 | Q9NQE9 | |
| VCTPGRLIDHVKKKA | 381 | Q86XP3 | |
| CSGHLKLPGKREIFV | 636 | P29323 | |
| PIAVKFLHRGNKELC | 131 | Q14D04 | |
| DKEHKCPLICGRKLR | 706 | Q12986 | |
| TLKAGDKSLPCHRLI | 36 | O60662 | |
| LKPKLIQASREGHCV | 2741 | P50851 | |
| PRIHDVLCKLVEKGE | 856 | P42704 | |
| HLRGKNCELLLVVPE | 176 | Q15040 | |
| CSLQDVLLHRKPKLG | 641 | Q6XUX3 | |
| LCVPDLKLSARPDKH | 646 | P53708 | |
| QCLPGKELHVKVLEG | 1296 | Q6V1P9 | |
| VHLELKDLTLCGRKG | 266 | Q9BZ23 | |
| VRAKCKEVTLHKDGP | 161 | Q92900 | |
| IDLAKKCLHIDPDKR | 261 | Q92772 | |
| DIALLKLKPVDGHCA | 411 | Q14520 | |
| IPKEHFGQRLLVKCL | 256 | Q96N67 | |
| RKKCLALVSLGEHPE | 1016 | O43497 | |
| KPIHQHEDRCLRLKV | 131 | P20827 | |
| EEPKHRHLGLRLCDK | 26 | P43004 | |
| KGLRLHDNPALKECI | 11 | Q16526 | |
| EECKEKRGIIPLDAH | 251 | Q9H4E7 | |
| KIPLRDCIKIGKHGE | 76 | Q92636 | |
| LVDKAPLRQKHLICG | 301 | Q5D0E6 | |
| LELCGVLHKYIKPRE | 36 | Q8N6R0 | |
| KALVGKLPGDHEVCK | 71 | Q9Y2H2 | |
| CKELRAHLELLPKTG | 841 | Q9C0B2 | |
| VRCIIPNHEKRAGKL | 676 | P35580 | |
| LAELGVLKKLCDHPR | 401 | Q2NKX8 | |
| KNCLPHRRGISILEK | 41 | Q8TB24 | |
| RHGLKEPKRVEELCN | 546 | Q92570 | |
| HAKQLIEEKIEGPLC | 486 | Q92945 | |
| KEIGAAVQALKCHPR | 291 | Q9HB19 | |
| EDARKRILCPLDPKH | 51 | Q9NUP7 | |
| KIGHLCKLLIDQGRI | 426 | Q9NUP7 | |
| ICPRDHKALLGLVKE | 281 | Q9HCM9 | |
| IEDIGKVLVCRAKLH | 186 | P19320 | |
| EHALKCLQREDPSLK | 506 | Q969S9 | |
| LAILEKCGAIPKIHS | 266 | Q9Y519 | |
| ELCHKFIAPGQKDRL | 296 | Q96I59 | |
| ELVKCLIHPRIKVGN | 406 | Q9Y2K3 | |
| DIHKRIALCIDGPKR | 586 | Q14CZ7 | |
| KGKACLLFDHLEPIE | 141 | Q8IV61 | |
| HCLKVILEKEGPRSL | 66 | Q96CQ1 | |
| DHPELVKLGSCKLIE | 336 | P78371 | |
| KHPSRVLKRDCGAIL | 836 | Q8NEZ3 | |
| KDLLEPGCSVLLNHK | 141 | P62191 | |
| HFLIECTPKGVRLKG | 1236 | Q68CZ2 | |
| LLKGLCHPRVKVGNE | 396 | P13533 | |
| ELLKELRHGVKICDV | 311 | Q9Y5B9 | |
| IDKPVCFVGRLEKIH | 21 | P35244 | |
| EIKPGVREIHLCKDE | 101 | Q9H190 | |
| EHRLNCPRELLAKAK | 266 | Q9Y2M2 | |
| LEDPVLCALAKKHKR | 236 | Q04828 | |
| LEDPVLCALAKKHKR | 236 | P52895 | |
| HLFSDGPDVKKLCIL | 1631 | Q96JI7 | |
| KLPSVDHKPKECLGL | 51 | Q96A04 | |
| LICRHEKPSALLKGR | 136 | P01135 | |
| CLEEGRHAKHEVKPL | 326 | Q6ZTA4 | |
| LKDHRCRLGPQKDKD | 726 | Q9BYN7 | |
| LCGEQRKKLIHTEDP | 151 | Q6ZU65 | |
| IPCSLKIRGIHAKEE | 26 | Q8IVF5 | |
| ENFRRHIKCELPLEK | 1456 | Q8IVF5 | |
| FEIKKCDLHRLEEGP | 36 | P08559 | |
| TEKKIPHECLVIGAL | 231 | Q9ULR3 | |
| IRPQLAKEKIEGCHI | 16 | Q7Z4S6 | |
| HVIRKDCGDDLSPIK | 271 | O95935 | |
| KARKCILAGDHKQLP | 391 | P38935 | |
| CHDGGLVLRDLKLRK | 166 | Q92519 | |
| ELSLGRKKAPHRLCG | 481 | Q96GP6 | |
| LGPAIKLCHQIERVK | 871 | Q5VUG0 | |
| NLEVEELKHPRAGCK | 281 | Q9UJ04 | |
| GLHKTLQPLVKRVCD | 466 | Q6UXI7 | |
| DIRCLLPKLSPGKHD | 1291 | Q86WI1 | |
| DGLCILDKKPLHEIK | 356 | Q6UXZ4 | |
| QRLKTIGVKHPELCK | 286 | Q8N2W9 | |
| CDKHKSILLKNGRDP | 66 | Q92979 | |
| LPKFHGVLKTLCLEV | 2386 | P78527 | |
| QGLLKKRLLPAEHCI | 551 | Q8NF64 | |
| AEKERLDKHLGIPCN | 221 | Q8NEG5 | |
| AADVLERHGPICKKL | 26 | Q5TFG8 | |
| HTIGELLIKPCAKDV | 211 | Q49AG3 | |
| LPEKEHGKICHLRED | 276 | Q969J2 | |
| AVTLKTIHLKRGPEC | 901 | O43592 | |
| ECGKGFPLKSRLIVH | 461 | O94892 | |
| LKLGPAIKLCHHIER | 841 | Q9UHJ3 | |
| VLRKDCPKIVEPHGK | 201 | O15535 | |
| KNKPREHIIDCGDIV | 96 | Q9Y6I7 | |
| KLLEAKHSGPRLCID | 116 | Q6PF06 | |
| LIHLGAKFSPCIRKD | 466 | Q6PJF5 | |
| LRIHKCKGPSDLLTV | 471 | Q8IWU6 | |
| LRASIDGCIKKLPVH | 251 | Q08AF3 | |
| ICEKVIQGAGKLPRH | 386 | O95365 | |
| LQGLLKKRLLPAEHC | 691 | Q9ULJ6 | |
| SVKEILGKCHPLGRF | 121 | Q8N8Y2 | |
| EEELCRLKLLAKHPC | 751 | O76024 | |
| DDGVKLLCEALKPHR | 966 | Q86W25 | |
| GICELLIPKLSKKDH | 1181 | P54296 |